41 – 50 of 353
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
- Contribution to journal › Article
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
- Contribution to journal › Scientific review
-
Mark
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
- Contribution to journal › Article
-
Mark
Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool
- Contribution to journal › Article
-
Mark
Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer : A Systematic Review
- Contribution to journal › Scientific review
- 2022
-
Mark
Artificial Intelligence-based Assessment of Prostate Cancer Metastases in PET/CT
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
- Contribution to journal › Article
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
(2022) p.131-172
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
- Contribution to journal › Article
